AMIVAS
  • Home
  • Products
    • ORDERING
      • Order Artesunate
    • MEDICAL INQUIRIES
      • Medical Affairs
      • Report Adverse Drug Reaction / Adverse Event
    • ARTESUNATE
      • Product Information
  • Severe Malaria
  • About
    • Careers
    • Partnering
  • News
  • Contact Us
Select Page
AMIVAS Launches Europe’s First & Only Licensed Severe Malaria Treatment

AMIVAS Launches Europe’s First & Only Licensed Severe Malaria Treatment

by admin | Oct 24, 2024 | Ticker

Artesunate AMIVAS® is now available for purchase across Europe and U.K. Artesunate AMIVAS®, approved by EU Commission and U.K.’s Medicine and Healthcare Product Regulatory Agency to treat severe malaria both in children and adults in Europe, is the only fully licensed...
AMIVAS IRELAND LTD. RECEIVES MHRA AUTHORISATION FOR UK

AMIVAS IRELAND LTD. RECEIVES MHRA AUTHORISATION FOR UK

by admin | Apr 5, 2023 | Press Releases

AMIVAS IRELAND LTD. RECEIVES AUTHORISATION FROM THE MEDICINES & HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) TO MARKET ARTESUNATE AMIVAS® (ARTESUNATE) IN UK FOR INITIAL TREATMENT OF SEVERE MALARIA amivas-ireland-ltd-mhra-authorisation...

Recent Posts

  • AMIVAS Launches Europe’s First & Only Licensed Severe Malaria Treatment
  • AMIVAS IRELAND LTD. RECEIVES MHRA AUTHORISATION FOR UK

Recent Comments

  1. A WordPress Commenter on AMIVAS IRELAND LTD. RECEIVES MHRA AUTHORISATION FOR UK

Artesunate for Injection® – USA        Artesunate Amivas® – EU

AMIVAS Inc.
  • Follow

ABOUT US

We are a pharmaceutical company delivering life-saving medicines to the world. We develop, commercialize and distribute Artesunate for severe malaria.

PRODUCT INFORMATION

Order Artesunate

Medical affairs

Product information

Report adverse drug reaction / adverse event

Severe malaria information

COMPANY

Home

Careers

Partnering

News

Contact

© Copyright 2026 AMIVAS. All Rights Reserved. Web Design by DIGITALO.